The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Twelve Month Follow-Up of CP0108
Official Title: Twelve Month Follow-Up Evaluation of Subjects Participating in DUSA-CP0108 (A Phase 3 Study of Photodynamic Therapy With Levulan Kerastick Topical Solution + Blue Light Versus Topical Solution Vehicle + Blue Light for the Treatment of Actinic Keratoses on the Upper Extremities)
Study ID: NCT02209012
Brief Summary: The purpose of this study is to determine the long-term safety and efficacy of Levulan PDT in subjects with multiple actinic keratosis of the upper extremities who received treatment as part of the DUSA CP0108 study.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Center For Dermatology Clinical Research, Inc., Fremont, California, United States
UCSD Dermatology, San Diego, California, United States
Center for Clinical and Cosmetic Research, Aventura, Florida, United States
MOORE Clinical Research, Inc, Brandon, Florida, United States
Spencer Clinical Services, St. Petersburg, Florida, United States
Altman Dermatology Associates, Arlington Heights, Illinois, United States
Shideler Clinical Research Center, Carmel, Indiana, United States
The Indiana Clinical Trials Center, PC, Plainfield, Indiana, United States
Minnesota Clinical Study Center, Fridley, Minnesota, United States
Oregon Dermatology and Research Center, Portland, Oregon, United States
J&S Studies, Inc, College Station, Texas, United States
Suzanne Bruce and Associates, P.A.,The Center for Skin Research, Houston, Texas, United States
Virginia Clinical Research, Inc., Norfolk, Virginia, United States
Name: Stuart Marcus, MD, PhD
Affiliation: DUSA Pharmaceuticals, Inc.
Role: STUDY_DIRECTOR